These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
468 related items for PubMed ID: 22361096
1. The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury. Gao J, Liu R, Wu J, Liu Z, Li J, Zhou J, Hao T, Wang Y, Du Z, Duan C, Wang C. Biomaterials; 2012 May; 33(14):3673-81. PubMed ID: 22361096 [Abstract] [Full Text] [Related]
2. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats. Zhuo W, Liao L, Fu Y, Xu T, Wu W, Yang S, Tan J. Transplant Proc; 2013 Mar; 45(2):503-10. PubMed ID: 23498785 [Abstract] [Full Text] [Related]
4. Adipose-derived mesenchymal stem cells therapy for acute kidney injury induced by ischemia-reperfusion in a rat model. Zhang JB, Wang XQ, Lu GL, Huang HS, Xu SY. Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1232-1240. PubMed ID: 28688148 [Abstract] [Full Text] [Related]
5. Use of mesenchymal stem cells and darbepoetin improve ischemia-induced acute kidney injury outcomes. Altun B, Yilmaz R, Aki T, Akoglu H, Zeybek D, Piskinpasa S, Uckan D, Purali N, Korkusuz P, Turgan C. Am J Nephrol; 2012 Dec; 35(6):531-9. PubMed ID: 22653289 [Abstract] [Full Text] [Related]
6. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats. Kim JH, Park DJ, Yun JC, Jung MH, Yeo HD, Kim HJ, Kim DW, Yang JI, Lee GW, Jeong SH, Roh GS, Chang SH. Am J Physiol Renal Physiol; 2012 May 01; 302(9):F1141-50. PubMed ID: 22205231 [Abstract] [Full Text] [Related]
7. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C, Camussi G. Nephrol Dial Transplant; 2011 May 01; 26(5):1474-83. PubMed ID: 21324974 [Abstract] [Full Text] [Related]
9. Adipose-Derived Mesenchymal Stromal Cells Under Hypoxia: Changes in Extracellular Vesicles Secretion and Improvement of Renal Recovery after Ischemic Injury. Collino F, Lopes JA, Corrêa S, Abdelhay E, Takiya CM, Wendt CHC, de Miranda KR, Vieyra A, Lindoso RS. Cell Physiol Biochem; 2019 May 01; 52(6):1463-1483. PubMed ID: 31099507 [Abstract] [Full Text] [Related]
10. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Liu Z, Wang H, Wang Y, Lin Q, Yao A, Cao F, Li D, Zhou J, Duan C, Du Z, Wang Y, Wang C. Biomaterials; 2012 Apr 01; 33(11):3093-106. PubMed ID: 22265788 [Abstract] [Full Text] [Related]
11. Mesenchymal stem cells in renal function recovery after acute kidney injury: use of a differentiating agent in a rat model. La Manna G, Bianchi F, Cappuccilli M, Cenacchi G, Tarantino L, Pasquinelli G, Valente S, Della Bella E, Cantoni S, Claudia C, Neri F, Tsivian M, Nardo B, Ventura C, Stefoni S. Cell Transplant; 2011 Apr 01; 20(8):1193-208. PubMed ID: 21092414 [Abstract] [Full Text] [Related]
12. Promotion of cardiac differentiation of brown adipose derived stem cells by chitosan hydrogel for repair after myocardial infarction. Wang H, Shi J, Wang Y, Yin Y, Wang L, Liu J, Liu Z, Duan C, Zhu P, Wang C. Biomaterials; 2014 Apr 01; 35(13):3986-98. PubMed ID: 24508080 [Abstract] [Full Text] [Related]
13. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury. Peng X, Xu H, Zhou Y, Wang B, Yan Y, Zhang X, Wang M, Gao S, Zhu W, Xu W, Qian H. Exp Biol Med (Maywood); 2013 Aug 01; 238(8):960-70. PubMed ID: 23970411 [Abstract] [Full Text] [Related]
14. Modulation of renal ischemia/reperfusion in rats by a combination of ischemic preconditioning and adipose-derived mesenchymal stem cells (ADMSCs). Hussein AM, Barakat N, Awadalla A, Gabr MM, Khater S, Harraz AM, Shokeir AA. Can J Physiol Pharmacol; 2016 Sep 01; 94(9):936-46. PubMed ID: 27411029 [Abstract] [Full Text] [Related]
15. Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy. Wang H, Shang Y, Chen X, Wang Z, Zhu D, Liu Y, Zhang C, Chen P, Wu J, Wu L, Kong D, Yang Z, Li Z, Chen X. Int J Nanomedicine; 2020 Sep 01; 15():4311-4324. PubMed ID: 32606679 [Abstract] [Full Text] [Related]
16. Immunological effects of the intraparenchymal administration of allogeneic and autologous adipose-derived mesenchymal stem cells after the acute phase of middle cerebral artery occlusion in rats. Yu Z, Wenyan T, Xuewen S, Baixiang D, Qian W, Zhaoyan W, Yinxiang Y, Suqing Q, Zuo L. J Transl Med; 2018 Dec 05; 16(1):339. PubMed ID: 30518375 [Abstract] [Full Text] [Related]
17. Comparison of human adipose stromal vascular fraction and adipose-derived mesenchymal stem cells for the attenuation of acute renal ischemia/reperfusion injury. Zhou L, Song Q, Shen J, Xu L, Xu Z, Wu R, Ge Y, Zhu J, Wu J, Dou Q, Jia R. Sci Rep; 2017 Mar 09; 7():44058. PubMed ID: 28276451 [Abstract] [Full Text] [Related]
18. Biocompatibility evaluation of chitosan-based injectable hydrogels for the culturing mice mesenchymal stem cells in vitro. Yan J, Yang L, Wang G, Xiao Y, Zhang B, Qi N. J Biomater Appl; 2010 Mar 09; 24(7):625-37. PubMed ID: 19451182 [Abstract] [Full Text] [Related]
19. Hypoxia-pretreated human MSCs attenuate acute kidney injury through enhanced angiogenic and antioxidative capacities. Zhang W, Liu L, Huo Y, Yang Y, Wang Y. Biomed Res Int; 2014 Mar 09; 2014():462472. PubMed ID: 25133162 [Abstract] [Full Text] [Related]
20. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Morigi M, Rota C, Montemurro T, Montelatici E, Lo Cicero V, Imberti B, Abbate M, Zoja C, Cassis P, Longaretti L, Rebulla P, Introna M, Capelli C, Benigni A, Remuzzi G, Lazzari L. Stem Cells; 2010 Mar 31; 28(3):513-22. PubMed ID: 20049901 [Abstract] [Full Text] [Related] Page: [Next] [New Search]